Table 2.
Results of the univariate analysis for AIGA positivity (n = 92).
| Variable | P | r | R2 |
|---|---|---|---|
| Types of infecting pathogens | 0.000 | 15,023.178 | 0.230 |
| No. of involved sites | 0.000 | 8598.168 | 0.310 |
| Underlying disease | 0.680 | 3436.103 | 0.003 |
| WBC × 109cells/L | 0.012 | 1048.2 | 0.107 |
| N × 109cells/L | 0.027 | 1019.579 | 0.085 |
| HGB g/L | 0.051 | − 275.4 | 0.066 |
| CD4+ T cell cells/µL | 0.000 | − 52.544 | 0.355 |
| IgG g/L | 0.000 | 2017.025 | 0.570 |
| IgM g/L | 0.010 | 13,142.694 | 0.150 |
| GLO g/L | 0.000 | 1250.074 | 0.347 |
| ESR mm/h | 0.002 | 293.641 | 0.180 |
| CRP mg/L | 0.000 | 211.043 | 0.279 |
Data were collected under sterile conditions before the patient received antimicrobial therapy and during the active stage of the infection. AIGA anti-IFN-γ autoantibodies; WBC white blood cell; N neutrophil count; ESR erythrocyte sedimentation rate; CRP C-reactive protein; Ig immunoglobulin. r regression coefficient.
Significant values are in [bold].